Abstract:Cataract formation is the leading cause of blindness across the globe. The eye lens is the onset site of cataract. The eye lens is densely packed with crystallins at a high concentration. Crystallins are categorized into 3 distinct families: alpha-, beta-, and gamma-CRYs. The alpha-CRYs are known to function as a small molecule chaperone, recognizing misfolded proteins and maintaining protein homeostasis in the lens. While the beta-/gamma-CRYs serve a key structural role in lens formation through intramolecular and intermolecular interactions. Crystallins are arranged in transiently short-range order within the lens fibers. In addition, the molecular recognition and dynamic protein interactions that are medicated by crystallins serve a critical role in maintaining the transparency of the eye lens. Protein homeostasis disorder in eye lens is the main pathogenic factors causing cataract. The crystallins have a long half-life and no longer renewed after protein synthesis. Therefore, the crystallins are highly susceptible to both the extracellular and intracellular factors, such as pH, metal ions, radiation damage and post-translational modifications. These factors disrupt molecular recognition of the crystallins or alter protein-protein interactions, resulting in cataract formation. Identifying the chemical regulatory principles of molecular recognition and protein interactions of the crystallins can help elucidate the molecular mechanisms that maintain or disrupt lens transparency, along with developing innovative treatment strategies for cataract. In this review, based on recent prowess in crystallins and cataracts, we comprehensively summarized the way of molecular recognition and protein interaction in the crystallins, as well as the regulatory factors. Recent technological innovations that were enabling us to characterize interactions between the crystallins were further discussed. In addition, we investigated the application values and challenges of protein-protein interaction networks that were dominated by the crystallins in the anti-cataract drug development.

[Protein Post-Translational Modification and Age-Related Cataract].

Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review)

The Proteome of Cataract Markers: Focus on Crystallins.

Human protein aging: modification and crosslinking through dehydroalanine and dehydrobutyrine intermediates

New insights into change of lens proteins' stability with ageing under physiological conditions

Research Progress of Molecular Recognition and Interaction of Crystallins Linking Cataract

Cataract formation and prevention

Glycation-mediated inter-protein cross-linking is promoted by chaperone–client complexes of α-crystallin: Implications for lens aging and presbyopia

Advances in Pharmacotherapy of Cataracts

The Oxidized Thiol Proteome in Aging and Cataractous Mouse and Human Lens Revealed by Icat Labeling

Proteomic Changes of Glycolipid Pathways in Age-Related, Diabetic, and Post-Vitrectomy Cataracts

Increasing Susceptibility to Oxidative Stress by Cataract-Causing Crystallin Mutations

Progress on pathogenesis, prevention and treatment of cataract

Proteomic changes in age‐related cataract and post‐vitrectomy cataract

Association of Alpha-Crystallin with Fiber Cell Plasma Membrane of the Eye Lens Accompanied by Light Scattering and Cataract Formation

Mutations of CX46/CX50 and Cataract Development

“Important Players” in the Development of Age-Related Cataracts (Literature Review)

Oxidative Stress, Epigenetic Regulation and Pathological Processes of Lens Epithelial Cells Underlying Diabetic Cataract.

Prevention of age-related truncation of γ-glutamylcysteine ligase catalytic subunit (GCLC) delays cataract formation

The Genetic Epidemiology of Age-Related Cataract

Role of micronutrients in the development of age-related cataract